2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Haloperidol: new trials by email Literature Review of Haloperidol trials Research Report on Haloperidol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose IXT-m200, Lorazepam, Haloperidol - Methamphetamine Intoxication (Disorder) | Phase 2 | Terminated | InterveXion Therapeutics, LLC | 20 | 2021-06-30 | 2023-11-18 |
| Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145) Preladenant, Placebo, Anticholinergic agents or propanolol - Akathisia, Drug-Induced, Antipsychotic Agents | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 46 | 2007-08-15 | 2018-11-07 |
Akathisia, Drug-Induced (1) · Movement Disorders (1)
InterveXion Therapeutics, LLC (1) · Merck Sharp & Dohme LLC (1)
United States (1)
U01DA053043 (1)